Page 125 - Read Online

Page 18 of 20 Vidoni et al. J Cancer Metastasis Treat 2021;7:4 I http://dx.doi.org/10.20517/2394-4722.2020.95

69. Kocaturk NM, Akkoc Y, Kig C, Bayraktar O, Gozuacik D, Kutlu O. Autophagy as a molecular target for cancer treatment. Eur J Pharm
Sci 2019;134:116-37.
70. Maycotte P, Jones KL, Goodall ML, Thorburn J, Thorburn A. Autophagy supports breast cancer stem cell maintenance by regulating IL6
secretion. Mol Cancer Res 2015;13:651-8.
71. Yun CW, Lee SH. The roles of autophagy in cancer. Int J Mol Sci 2018;19:3466.
72. Vera-Ramirez L, Vodnala SK, Nini R, Hunter KW, Green JE. Autophagy promotes the survival of dormant breast cancer cells and
metastatic tumour recurrence. Nat Commun 2018;9:1944.
73. Gomes LR, Vessoni AT, Menck CFM. Microenvironment and autophagy cross-talk: Implications in cancer therapy. Pharmacol Res
2016;107:300-7.
74. Martinez-Outschoorn U, Sotgia F, Lisanti MP. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of
mitochondrial fuels and function. Semin Oncol 2014;41:195-216.
75. Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer
cells, fueling tumor growth. Semin Cancer Biol 2014;25:47-60.
76. Ferraresi A, Girone C, Esposito A, et al. How autophagy shapes the tumor microenvironment in ovarian cancer. Front Oncol
2020;10:599915.
77. Yan YL, Chen X, Wang X, et al. The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer. J Exp Clin
Cancer Res 2019;38:171.
78. Zhao LJ, Ji GL, Le XB, et al. Long noncoding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression
of ovarian cancer. Cancer Res 2017;77:1369-82.
79. Zhang XY, Zhang M, Cong Q, et al. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced
autophagy. Int J Biochem Cell Biol 2018;95:9-16.
80. Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Invest 2016;126:2775-82.
81. Mendell JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005;4:1179-84.
82. Patil N, Allgayer H, Leupold JH. MicroRNAs in the tumor microenvironment. In: Birbrair A, editor. Tumor Microenvironment. Cham:
Springer International Publishing; 2020. p. 1-31.
83. Ren J, Ding L, Zhang D, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by
transferring exosomal lncRNA H19. Theranostics 2018;8:3932-48.
84. Herrera M, Llorens C, Rodríguez M, et al. Differential distribution and enrichment of non-coding RNAs in exosomes from normal and
Cancer-associated fibroblasts in colorectal cancer. Mol Cancer 2018;17:114.
85. Donnarumma E, Fiore D, Nappa M, et al. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive
phenotype in breast cancer. Oncotarget 2017;8:19592-608.
86. Wen J, Yeo S, Wang CR, et al. Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast
cancer cells to chemotherapy-induced apoptosis. Breast Cancer Res Treat 2015;149:619-29.
87. Ueno T, Saji S, Sugimoto M, et al. Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer
patients who received neoadjuvant endocrine therapy. BMC Cancer 2016;16:230.
88. Cook KL, Wärri A, Soto-Pantoja DR, et al. Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+
breast cancer. Clin Cancer Res 2014;20:3222-32.
89. Aydinlik S, Erkisa M, Cevatemre B, et al. Enhanced cytotoxic activity of doxorubicin through the inhibition of autophagy in triple
negative breast cancer cell line. Biochim Biophys Acta Gen Subj 2017;1861:49-57.
90. Pagotto A, Pilotto G, Mazzoldi EL, et al. Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian
cancer stem cells. Cell Death Dis 2017;8:e2943.
91. Minamoto T, Nakayama K, Nakamura K, et al. Loss of beclin 1 expression in ovarian cancer: A potential biomarker for predicting
unfavorable outcomes. Oncol Lett 2018;15:1170-6.
92. Jia JH, Yang XX, Zhao Q, et al. BNIP3 contributes to cisplatin-induced apoptosis in ovarian cancer cells. FEBS Open Bio 2020;10:1463-73.
93. Surviladze Z, Sterk RT, DeHaro SA, Ozbun MA. Cellular entry of human papillomavirus type 16 involves activation of the
phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. J Virol 2013;87:2508-17.
94. Titone R, Morani F, Follo C, Vidoni C, Mezzanzanica D, Isidoro C. Epigenetic control of autophagy by microRNAs in ovarian cancer.
Biomed Res Int 2014;2014:343542.
95. Yang XJ, Zhong XM, Tanyi JL, et al. MiR-30d Regulates multiple genes in the autophagy pathway and impairs autophagy process in
human cancer cells. Biochem Biophys Res Commun 2013;431:617-22.
96. Dai FR, Zhang Y, Chen YX. Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma.
Hum Pathol 2014;45:1285-93.
97. Jia Y, Lin RX, Jin HJ, et al. MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis
and inhibits cell invasion by targeting Notch 1. Biochimie 2019;160:193-9.
98. Wu YR, Ni ZH, Yan XJ, et al. Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to
pirarubicin. Autophagy 2016;12:1105-17.
99. Yang FX, Guo L, Cao YJ, Li SZ, Li JH, Liu M. MicroRNA-7-5p promotes cisplatin resistance of cervical cancer cells and modulation of
cellular energy homeostasis by regulating the expression of the PARP-1 and BCL2 genes. Med Sci Monit 2018;24:6506-16.
100. Tang H, Sebti S, Titone R, et al. Decreased BECN1 mRNA Expression in human breast cancer is associated with estrogen receptor-
negative subtypes and poor prognosis. EBioMedicine 2015;2:255-63.